Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening-Reference-Cited by-同舟云学术

Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening

Published:2018-07-01 Issue:7 Volume:172 Page:696
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Hopkins Patrick V.¹,Klug Tracy¹,Vermette Lacey¹,Raburn-Miller Julie²,Kiesling Jami²,Rogers Sharmini²

Affiliation:

1. Missouri State Public Health Laboratory, Jefferson City

2. Department of Health and Senior Services, Jefferson City, Missouri

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology, and Child Health

Reference5 articles.

1. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.;Hopkins;J Pediatr,2015

2. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.;Sista;Clin Chim Acta,2013

3. Newborn screening for lysosomal storage disorders.;Matern;Semin Perinatol,2015

4. Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience.;Burton;J Pediatr,2017

5. Health Resources and Services Administration (HRSA). Recommended Uniform Screening Panel Core Conditions. https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendedpanel/uniformscreeningpanel.pdf. November 2016. Accessed November 1, 2017.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Three Years’ Experience of Mucopolysaccharidosis Type-I Newborn Screening in California;The Journal of Pediatrics;2023-12

2. Cardiac surgery of aortic valve and ascending aorta (Bentall procedure) in a patient with Fabry disease without enzyme replacement therapy: an overview of aortic and aortic valve surgical tips;Journal of Renal Injury Prevention;2023-07-29

3. Newborn Screening for Mucopolysaccharidosis Type I: Past, Present and Future;OBM Genetics;2023-07-24

4. Obtaining the best igRNAs for bystander-less correction of all ABE-reversible pathogenic SNVs using high-throughput screening;Molecular Therapy;2023-04

5. Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients;Nutrients;2023-01-28